Feeding conditions differentially affect the neurochemical and behavioral effects of dopaminergic drugs in male rats

European Journal of Pharmacology

Volumn 592, Issue 1-3, 2008, Pages 109-115

  Sevak, Rajkumar J ^a   Koek, Wouter ^a,b   Owens, William Anthony ^a   Galli, Aurelio ^c   Daws, Lynette C ^a   France, Charles P ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; Chronoamperometry; Conditioned place preference; Dopamine; Locomotion; Quinpirole; Raclopride; Receptor

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ASCORBIC ACID; CHLORALOSE; DEXAMPHETAMINE; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE TRANSPORTER; GLUCOSE; INSULIN; QUINPIROLE; RACLOPRIDE; SODIUM CHLORIDE; URETHAN;

AMPEROMETRY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CATALEPSY; CHRONOAMPEROMETRY; COMORBIDITY; CONDITIONING; CONTROLLED STUDY; DIET RESTRICTION; DOPAMINERGIC SYSTEM; DRUG ABUSE; DRUG DOSE INCREASE; DRUG EFFECT; EATING DISORDER; FEEDING BEHAVIOR; GLUCOSE BLOOD LEVEL; LOCOMOTION; MALE; NEUROTRANSMISSION; NONHUMAN; NUTRITIONAL STATUS; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; SUBSTANCE ABUSE; YAWNING;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; BODY WEIGHT; BRAIN CHEMISTRY; CALORIC RESTRICTION; CATALEPSY; CONDITIONING, OPERANT; DIABETES MELLITUS, EXPERIMENTAL; DOPAMINE; DOPAMINE AGENTS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; MALE; MOTOR ACTIVITY; NUTRITIONAL STATUS; QUINPIROLE; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; YAWNING;

EID: 49749112009     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.07.002     Document Type: Article

References (48)

1. 2 receptor in rat ventral tegmental area. Neurosci. Lett. 347 (2003) 89-92
2. Belin D., and Everitt B.J. Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking ventral with the dorsal striatum. Neuron 57 (2008) 432-441
3. Bell S.M., Stewart R.B., Thompson S.C., and Meisch R.A. Food-deprivation increases cocaine-induced conditioned place preference and locomotor activity in rats. Psychopharmacology (Berl.) 131 (1997) 1-8
4. Benomar Y., Naour N., Aubourg A., Bailleux V., Gertler A., Djiane J., Guerre-Millo M., and Taouis M. Insulin and leptin induce Glut4 plasma membrane translocation and glucose uptake in a human neuronal cell line by a phosphatidylinositol 3-kinase-dependent mechanism. Endocrinology 147 (2006) 2550-2556
5. Carr K.D. Feeding, drug abuse, and the sensitization of reward by metabolic need. Neurochem. Res. 21 (1996) 1455-1467
6. Carr K.D., Kim G.Y., and Cabeza de Vaca S. Rewarding and locomotor-activating effects of direct dopamine receptor agonists are augmented by chronic food restriction in rats. Psychopharmacology (Berl.) 154 (2001) 420-428
7. Carr K.D., Tsimberg Y., Berman Y., and Yamamoto N. Evidence of increased dopamine receptor signaling in food-restricted rats. Neuroscience 119 (2003) 1157-1167
8. Carroll M.E., France C.P., and Meisch R.A. Intravenous self-administration of etonitazene, cocaine and phencyclidine in rats during food deprivation and satiation. J. Pharmacol. Exp. Ther. 217 (1981) 241-247
9. Carvelli L., Moron J.A., Kahlig K.M., Ferrer J.V., Sen N., Lechleiter J.D., Leeb-Lundberg L.M., Merrill G., Lafer E.M., Ballou L.M., Shippenberg T.S., Javitch J.A., Lin R.Z., and Galli A. PI 3-kinase regulation of dopamine uptake. J. Neurochem. 81 (2002) 859-869
10. 2 dopamine receptors can modulate dopamine uptake. Neurosci. Lett. 176 (1994) 259-263
11. Cass W.A., and Gerhardt G.A. In vivo assessment of dopamine uptake in rat medial prefrontal cortex: comparison with dorsal striatum and nucleus accumbens. J. Neurochem. 65 (1995) 201-207
12. Ciliax B.J., Heilman C., Demchyshyn L.L., Pristupa Z.B., Ince E., Hersche S.M., Niznik H.B., and Levey A.I. The dopamine transporter - immunochemical characterization and localization in brain. J. Neurosci. 15 (1995) 1714-1723
13. 2 receptor-mediated effects. J. Pharmacol. Exp. Ther. 325 (2008) 691-697
14. Copeland B.J., Neff N.H., and Hadjiconstantinou M. Enhanced dopamine uptake in the striatum following repeated restraint stress. Synapse 57 (2005) 167-174
15. 2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J. Neurochem. 72 (1999) 148-156
16. Drouin C., Darracq L., Trovero F., Blanc G., Glowinski J., Cotecchia S., and Tassin J.P. Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J. Neurosci. 22 (2002) 2873-2884
17. Everitt B.J., and Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 8 (2005) 1481-1489
18. 3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter. Eur. J. Neurosci. 12 (2000) 19-26
19. Figlewicz D.P., Brot M.D., McCall A.L., and Szot P. Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study. Brain. Res. 736 (1996) 54-60
20. Frantz K.J., and Van Hartesveldt C. The locomotor effects of quinpirole in rats depend on age and gender. Pharmacol. Biochem. Behav. 64 (1999) 821-826
21. Fuxe K., Agnati L.F., Kalia M., Goldstein M., Andersson K., and Hlfstrand A. Dopaminergic systems in the brain and pituitary. In: Fliickiger E., Miller E.E., and Thorner M.O. (Eds). The Dopaminergic System (1985), Springer Sandoz, New York 1-25
22. Giros B., Jaber M., Jones S.R., Wightman R.M., and Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 (1996) 606-612
23. Han D.D., and Gu H.H. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol. 6 (2006) 6
24. Haraldseth O., Jones R.A., and Skottner A. A quantitative in-vivo MR imaging study of brain dehydration in diabetic rats and rats treated with peptide hormones. Magn. Reson. Imaging 15 (1997) 203-210
25. Havel P.J., Uriu-Hare J.Y., Liu T., Stanhope K.L., Stern J.S., Keen C.L., and Ahren B. Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin. Am. J. Physiol. 274 (1998) R1482-R1491
26. Hilber B., Scholze P., Dorostkar M.M., Sandtner W., Holy M., Boehm S., Singer E.A., and Sitte H.H. Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines. Neuropharmacology 49 (2005) 811-819
27. Jones S.R., Gainetdinov R.R., Hu X.T., Cooper D.C., Wightman R.M., White F.J., and Caron M.G. Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat. Neurosci. 2 (1999) 649-655
28. Kahlig K.M., and Galli A. Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine. Eur. J. Pharmacol. 479 (2003) 153-158
29. Knusel B., Michel P.P., Schwaber J.S., and Hefti F. Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J. Neurosci. 10 (1990) 558-570
30. Kuczenski R., and Segal D.S. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J. Pharmacol. Exp. Ther. 296 (2001) 876-883
31. McCann U.D., Kuwabara H., Kumar A., Palermo M., Abbey R., Brasic J., Ye W., Alexander M., Dannals R.F., Wong D.F., and Ricaurte G.A. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse 62 (2008) 91-100
32. Oatley K., and Tonge D.A. The effect of hunger on water intake in rats. Q. J. Exp. Psychol. 21 (1969) 162-171
33. Owens W.A., Sevak R.J., Galici R., Galli A., France C.P., and Daws L.C. Deficits in dopamine clearance and locomotion in hypoinsulinemic rats are restored by repeated administration of amphetamine. J. Neurochem. 94 (2005) 1402-1410
34. Patterson T.A., Brot M.D., Zavosh A., Schenk J.O., Szot P., and Figlewicz D.P. Food deprivation decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology 68 (1998) 11-20
35. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, New York
36. Pothos E.N., Creese I., and Hoebel B.G. Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake. J. Neurosci. 15 (1995) 6640-6650
37. Rothman R.B., and Baumann M.H. Monoamine transporters and psychostimulant drugs. Eur. J. Pharmacol. 479 (2003) 23-40
38. Rothman R.B., Baumann M.H., Dersch C.M., Romero D.V., Rice K.C., Carroll F.I., and Partilla J.S. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39 (2001) 32-41
39. Russo S.J., Bolanos C.A., Theobald D.E., Decarolis N.A., Renthal W., Kumar A., Winstanley C.A., Renthal N.E., Wiley M.D., Self D.W., Russell D.S., Neve R.L., Eisch A.J., and Nestler E.J. IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat. Neurosci. 10 (2007) 93-99
40. 2 high receptors occupied by endogenous dopamine, even in the absence of acute challenge. Synapse 46 (2002) 235-239
41. Sevak R.J., Koek W., and France C.P. Streptozotocin-induced diabetes differentially modifies haloperidol- and gamma-hydroxybutyric acid (GHB)-induced catalepsy. Eur. J. Pharmacol. 517 (2005) 64-67
42. Sevak R.J., Koek W., Galli A., and France C.P. Insulin replacement restores the behavioral effects of quinpirole and raclopride in streptozotocin-treated rats. J. 12Pharmacol. Exp. Ther. 320 (2007) 1216-1223
43. 2 receptor mediation of amphetamine-induced normalization of locomotion and dopamine transporter function in hypoinsulinemic rats. J. Neurochem. 101 (2007) 151-159
44. Sevak R.J., Koek W., Daws L.C., Owens W.A., Galli A., and France C.P. Behavioral effects of amphetamine in streptozotocin-treated rats. Eur. J. Pharmacol. 581 (2008) 105-112
45. Stuber G.D., Evans S.B., Higgins M.S., Pu Y., and Figlewicz D.P. Food restriction modulates amphetamine-conditioned place preference and nucleus accumbens dopamine release in the rat. Synapse 46 (2002) 83-90
46. Wolfe W.L., and Maisto S.A. The relationship between eating disorders and substance abuse: moving beyond co-prevalence research. Clin. Psychol. Rev. 20 (2000) 617-631
47. --dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Ther. 92 (2001) 21-55
48. Zhen J., Maarten E.A.R., and Carr K.D. Chronic food restriction and dopamine transporter function in rat striatum. Brain Res. 1082 (2006) 98-101